256 related articles for article (PubMed ID: 15574764)
1. Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors.
Papassava P; Gorgoulis VG; Papaevangeliou D; Vlahopoulos S; van Dam H; Zoumpourlis V
Cancer Res; 2004 Dec; 64(23):8573-84. PubMed ID: 15574764
[TBL] [Abstract][Full Text] [Related]
2. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
Recio JA; Merlino G
Oncogene; 2002 Feb; 21(7):1000-8. PubMed ID: 11850817
[TBL] [Abstract][Full Text] [Related]
4. Injury-specific expression of activating transcription factor-3 in retinal ganglion cells and its colocalized expression with phosphorylated c-Jun.
Takeda M; Kato H; Takamiya A; Yoshida A; Kiyama H
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2412-21. PubMed ID: 10937548
[TBL] [Abstract][Full Text] [Related]
5. The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription.
James CG; Woods A; Underhill TM; Beier F
BMC Mol Biol; 2006 Sep; 7():30. PubMed ID: 16984628
[TBL] [Abstract][Full Text] [Related]
6. Activation of the rat cyclin A promoter by ATF2 and Jun family members and its suppression by ATF4.
Shimizu M; Nomura Y; Suzuki H; Ichikawa E; Takeuchi A; Suzuki M; Nakamura T; Nakajima T; Oda K
Exp Cell Res; 1998 Feb; 239(1):93-103. PubMed ID: 9511728
[TBL] [Abstract][Full Text] [Related]
7. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
[TBL] [Abstract][Full Text] [Related]
8. Activator protein 1 transcription factors are fundamental to v-rasHa-induced changes in gene expression in neoplastic keratinocytes.
Rutberg SE; Adams TL; Glick A; Bonovich MT; Vinson C; Yuspa SH
Cancer Res; 2000 Nov; 60(22):6332-8. PubMed ID: 11103794
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor ATF-2 inhibits extracellular signal regulated kinase expression and proliferation of human cancer cells.
Crowe DL; Shemirani B
Anticancer Res; 2000; 20(5A):2945-9. PubMed ID: 11062705
[TBL] [Abstract][Full Text] [Related]
10. Transactivation of the ApoCIII promoter by ATF-2 and repression by members of the Jun family.
Hadzopoulou-Cladaras M; Lavrentiadou SN; Zannis VI; Kardassis D
Biochemistry; 1998 Oct; 37(40):14078-87. PubMed ID: 9760243
[TBL] [Abstract][Full Text] [Related]
11. Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model.
Cooper SJ; MacGowan J; Ranger-Moore J; Young MR; Colburn NH; Bowden GT
Mol Cancer Res; 2003 Sep; 1(11):848-54. PubMed ID: 14517347
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
[TBL] [Abstract][Full Text] [Related]
13. A dominant negative c-jun specifically blocks okadaic acid-induced skin tumor promotion.
Thompson EJ; MacGowan J; Young MR; Colburn N; Bowden GT
Cancer Res; 2002 Jun; 62(11):3044-7. PubMed ID: 12036911
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis.
van Dam H; Castellazzi M
Oncogene; 2001 Apr; 20(19):2453-64. PubMed ID: 11402340
[TBL] [Abstract][Full Text] [Related]
15. Role of basic region leucine zipper transcription factors cyclic AMP response element binding protein (CREB), CREB2, activating transcription factor 2 and CAAT/enhancer binding protein alpha in cyclic AMP response element-mediated transcription.
Thiel G; Al Sarraj J; Vinson C; Stefano L; Bach K
J Neurochem; 2005 Jan; 92(2):321-36. PubMed ID: 15663480
[TBL] [Abstract][Full Text] [Related]
16. Jun signalling in the epidermis: From developmental defects to psoriasis and skin tumors.
Zenz R; Wagner EF
Int J Biochem Cell Biol; 2006; 38(7):1043-9. PubMed ID: 16423552
[TBL] [Abstract][Full Text] [Related]
17. Activating transcription factor 2 targets c-Fos, but not c-Jun, in growth plate chondrocytes.
Li X; LuValle P
J Cell Biochem; 2011 Jan; 112(1):211-6. PubMed ID: 21069729
[TBL] [Abstract][Full Text] [Related]
18. Adrenomedullin promotes cell cycle transit and up-regulates cyclin D1 protein level in human glioblastoma cells through the activation of c-Jun/JNK/AP-1 signal transduction pathway.
Ouafik L; Berenguer-Daize C; Berthois Y
Cell Signal; 2009 Apr; 21(4):597-608. PubMed ID: 19166930
[TBL] [Abstract][Full Text] [Related]
19. Activation of c-Jun and ATF-2 in primate motor cranial nerve nuclei is not associated with apoptosis following axotomy.
Colby GP; Coon AL; Connolly ES; Ambron RT
Exp Neurol; 2005 Jul; 194(1):57-65. PubMed ID: 15899243
[TBL] [Abstract][Full Text] [Related]
20. JunB negatively regulates AP-1 activity and cell proliferation of malignant mouse keratinocytes.
Finch S; Joseloff E; Bowden T
J Cancer Res Clin Oncol; 2002 Jan; 128(1):3-10. PubMed ID: 11862466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
